Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1985 6
1986 9
1987 17
1988 30
1989 41
1990 37
1991 56
1992 45
1993 58
1994 89
1995 77
1996 83
1997 98
1998 98
1999 108
2000 101
2001 80
2002 113
2003 106
2004 134
2005 125
2006 125
2007 136
2008 167
2009 134
2010 139
2011 159
2012 170
2013 163
2014 198
2015 213
2016 250
2017 265
2018 274
2019 291
2020 334
2021 327
2022 282
2023 282
2024 284
2025 348
2026 222

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,499 results

Results by year

Filters applied: . Clear all
Page 1
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, Emaus MJ, Loo CE, Bisschops RHC, Lobbes MBI, de Jong MDF, Duvivier KM, Veltman J, Karssemeijer N, de Koning HJ, van Diest PJ, Mali WPTM, van den Bosch MAAJ, Veldhuis WB, van Gils CH; DENSE Trial Study Group. Bakker MF, et al. N Engl J Med. 2019 Nov 28;381(22):2091-2102. doi: 10.1056/NEJMoa1903986. N Engl J Med. 2019. PMID: 31774954 Clinical Trial.
BACKGROUND: Extremely dense breast tissue is a risk factor for breast cancer and limits the detection of cancer with mammography. Data are needed on the use of supplemental magnetic resonance imaging (MRI) to improve early …
BACKGROUND: Extremely dense breast tissue is a risk factor for breast cancer and limits the detection of cancer with ma …
Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis.
Quanyang W, Yao H, Sicong W, Linlin Q, Zewei Z, Donghui H, Hongjia L, Shijun Z. Quanyang W, et al. Cancer Med. 2024 Apr;13(7):e7140. doi: 10.1002/cam4.7140. Cancer Med. 2024. PMID: 38581113 Free PMC article. Review.
It then explores the applications of AI in lung cancer screening, including lung segmentation, nodule detection, and classification, and assesses the potential of AI in enhancing the sensitivity of nodule detection and reducing false-positive …
It then explores the applications of AI in lung cancer screening, including lung segmentation, nodule detection, and cl …
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.
McHugh JK, Bancroft EK, Saunders E, Brook MN, McGrowder E, Wakerell S, James D, Rageevakumar R, Benton B, Taylor N, Myhill K, Hogben M, Kinsella N, Sohaib AA, Cahill D, Hazell S, Withey SJ, Mcaddy N, Page EC, Osborne A, Benafif S, Jones AB, Patel D, Huang DY, Kaur K, Russell B, Nicholson R, Croft F, Sobczak J, McNally C, Mutch F, Bennett S, Kingston L, Karlsson Q, Dadaev T, Saya S, Merson S, Wood A, Dennis N, Hussain N, Thwaites A, Hussain S, Rafi I, Ferris M, Kumar P, James ND, Pashayan N, Kote-Jarai Z, Eeles RA; BARCODE1 Steering Committee and Collaborators. McHugh JK, et al. N Engl J Med. 2025 Apr 10;392(14):1406-1417. doi: 10.1056/NEJMoa2407934. N Engl J Med. 2025. PMID: 40214032 Free PMC article.
BACKGROUND: The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a high rate for false positive results. ...Using germline DNA extracted from saliva, we derived polygenic risk scores from 130 va …
BACKGROUND: The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a h …
ESR Essentials: screening for breast cancer - general recommendations by EUSOBI.
Marcon M, Fuchsjäger MH, Clauser P, Mann RM. Marcon M, et al. Eur Radiol. 2024 Oct;34(10):6348-6357. doi: 10.1007/s00330-024-10740-5. Epub 2024 Apr 24. Eur Radiol. 2024. PMID: 38656711 Free PMC article.
This approach has some recognized limitations, including underdiagnosis, false positive cases, and overdiagnosis. Indeed, breast cancer remains a major cause of cancer-related deaths in women undergoing cancer screening. ...KEY RECOMMENDA …
This approach has some recognized limitations, including underdiagnosis, false positive cases, and overdiagnosis. Indeed, brea …
Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis.
Wekking D, Porcu M, De Silva P, Saba L, Scartozzi M, Solinas C. Wekking D, et al. Curr Oncol Rep. 2023 Apr;25(4):257-267. doi: 10.1007/s11912-023-01372-x. Epub 2023 Feb 7. Curr Oncol Rep. 2023. PMID: 36749493 Review.
PURPOSE OF REVIEW: This article aims to provide an updated overview of the indications for diagnostic breast magnetic resonance imaging (MRI), discusses the available and novel imaging exams proposed for breast cancer detection, an …
PURPOSE OF REVIEW: This article aims to provide an updated overview of the indications for diagnostic breast magnetic resonance …
Screening for Breast Cancer with Contrast-enhanced Mammography as an Alternative to MRI: SCEMAM Trial Results.
Berg WA, Vargo A, Lu AH, Berg JM, Bandos AI, Hartman JY, Zuley ML, Ganott MA, Kelly AE, Nair BE, Chough DM, Reginella RF, Wallace LP, Harnist KS, Carlin BA, Cohen CS, Hakim CM, Sumkin JH. Berg WA, et al. Radiology. 2025 Jun;315(3):e242634. doi: 10.1148/radiol.242634. Radiology. 2025. PMID: 40525975 Clinical Trial.
Background Many state laws require insurance coverage for supplemental screening MRI in women at elevated risk for breast cancer, but MRI capacity is limited. Purpose To evaluate the impact of contrast-enhanced mammography (CEM) on incremental cance …
Background Many state laws require insurance coverage for supplemental screening MRI in women at elevated risk for breast c …
Reducing False-Positive Screening MRI Rate in Women with Extremely Dense Breasts Using Prediction Models Based on Data from the DENSE Trial.
den Dekker BM, Bakker MF, de Lange SV, Veldhuis WB, van Diest PJ, Duvivier KM, Lobbes MBI, Loo CE, Mann RM, Monninkhof EM, Veltman J, Pijnappel RM, van Gils CH; DENSE Trial Study Group. den Dekker BM, et al. Radiology. 2021 Nov;301(2):283-292. doi: 10.1148/radiol.2021210325. Epub 2021 Aug 17. Radiology. 2021. PMID: 34402665 Clinical Trial.
Background High breast density increases breast cancer risk and lowers mammographic sensitivity. Supplemental MRI screening improves cancer detection but increases the number of false-positive screenings. Thus, methods to di …
Background High breast density increases breast cancer risk and lowers mammographic sensitivity. Supplemental MRI screening …
Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Henderson JT, Webber EM, Weyrich MS, Miller M, Melnikow J. Henderson JT, et al. JAMA. 2024 Jun 11;331(22):1931-1946. doi: 10.1001/jama.2023.25844. JAMA. 2024. PMID: 38687490
IMPORTANCE: Breast cancer is a leading cause of cancer mortality for US women. Trials have established that screening mammography can reduce mortality risk, but optimal screening ages, intervals, and modalities for population screening guideline …
IMPORTANCE: Breast cancer is a leading cause of cancer mortality for US women. Trials have established that screening m …
Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density.
Stout NK, Miglioretti DL, Su YR, Lee CI, Abraham L, Alagoz O, de Koning HJ, Hampton JM, Henderson L, Lowry KP, Mandelblatt JS, Onega T, Schechter CB, Sprague BL, Stein S, Trentham-Dietz A, van Ravesteyn NT, Wernli KJ, Kerlikowske K, Tosteson ANA. Stout NK, et al. JAMA Intern Med. 2024 Oct 1;184(10):1222-1231. doi: 10.1001/jamainternmed.2024.4224. JAMA Intern Med. 2024. PMID: 39186304 Free PMC article.
IMPORTANCE: Information on long-term benefits and harms of screening with digital breast tomosynthesis (DBT) with or without supplemental breast magnetic resonance imaging (MRI) is needed for clinical and policy discussions, particularly for pat …
IMPORTANCE: Information on long-term benefits and harms of screening with digital breast tomosynthesis (DBT) with or without suppleme …
5,499 results